Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) AcceptanceUnusual Whales·Jul 8 at 08:05 AM300363-1.51%
07:08 ETChina-US Dual Filing Success: Porton Advanced's End-to-End Bacterial Vector CDMO Solution Accelerates NMPA Approval of Salvectors' Innovative Oncolytic Bacteria Therapyprnewswire·May 28 at 06:10 AM300363-1.51%
Porton released its performance for the first three quarters, with a net profit attributable to the parent company of 79.9154 million yuan, an increase of 138.71%Zhitong·Oct 24, 2025 at 06:19 AM300363-1.51%
Porton issued a profit warning, expecting a net profit attributable to shareholders of 73.2 million to 88.2 million yuan in the first three quarters, turning losses into profitsZhitong·Oct 13, 2025 at 05:38 AM300363-1.51%
Innovative drug concept stocks fluctuate and rise, DEZHAN HEALTHCARE hits the limit upZhitong·Sep 14, 2025 at 08:43 PM603127-3.58%06127-1.26%
Zhejiang Merchants Securities: The growth trend of the CXO sector in 25H1 continues to improve, and the construction projects remain at a high levelZhitong·Sep 11, 2025 at 01:19 AM300347+5.66%03347+3.49%
Porton Biotech and Tianyu Life have reached a strategic cooperation to jointly promote the research and commercialization of NK cell therapyZhitong·Sep 3, 2025 at 03:43 AM300363-1.51%
Innovative drug concept stocks rose at the beginning of the trading session, YKYY increased by over 10%Zhitong·Sep 2, 2025 at 08:41 PM300255-2.27%300363-1.51%
CRO concept stocks remain active, Porton rises nearly 10%Zhitong·Jul 24, 2025 at 08:50 PM300363-1.51%
CRO concept stocks surged again, WuXi AppTec hit the daily limit, Porton reached a 20% limit up, Medicilon rose over 10%, Asymchem and Pharmaron had significant gainsZhitong·Jul 10, 2025 at 09:25 PM002821-1.49%06821-0.77%
Porton subsidiary Porton Intelligent Expansion passes EU QP auditZhitong·Jun 18, 2025 at 04:05 AM300363-1.51%
